LONGMONT - Acertara Acoustic Laboratories LLC is set to launch a system that tests ultrasound equipment.

Longmont-based Acertara will present Aureon, the first commercial ultrasound acoustic dose- analysis and field-mapping system in June at an industry expo in California put on by the Association for The Advancement of Medical Instrumentation.

The device, which will sell for $60,000, can detect flaws or early failures in ultrasound probe equipment regardless of the manufacturer, according to the company. The target market for the device includes hospitals, ultrasound research laboratories, regulatory agency laboratories and original equipment manufacturers.

"Ultrasound probe design is becoming increasingly more complex," said G. Wayne Moore, president and chief executive of Acertara, "as evidenced by the recent introduction of 2-D matrix arrays with as many as 9,000 elements." Aureon can detect variations in emitted acoustic power down to a single element even in a large array, he said.

Moore said the equipment can enhance patient safety and the results of an ultrasound examination.

Acertara was founded in June 2012 by Moore and James Gessert, co-founders of Sonora Medical Systems Inc.